DK0859615T3 - Carbostyrilderivat til helbredelse af ophthalmologiske sygdomme - Google Patents

Carbostyrilderivat til helbredelse af ophthalmologiske sygdomme

Info

Publication number
DK0859615T3
DK0859615T3 DK96932058T DK96932058T DK0859615T3 DK 0859615 T3 DK0859615 T3 DK 0859615T3 DK 96932058 T DK96932058 T DK 96932058T DK 96932058 T DK96932058 T DK 96932058T DK 0859615 T3 DK0859615 T3 DK 0859615T3
Authority
DK
Denmark
Prior art keywords
cure
carbostyril derivative
ophthalmological diseases
ophthalmological
diseases
Prior art date
Application number
DK96932058T
Other languages
English (en)
Inventor
Hiroki Urashima
Yasuhiro Takeji
Hisashi Shinohara
Shigeki Fujisawa
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Application granted granted Critical
Publication of DK0859615T3 publication Critical patent/DK0859615T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/47042-Quinolinones, e.g. carbostyril
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK96932058T 1995-10-12 1996-10-01 Carbostyrilderivat til helbredelse af ophthalmologiske sygdomme DK0859615T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP26389695 1995-10-12
JP5733796 1996-03-14
PCT/JP1996/002850 WO1997013515A1 (en) 1995-10-12 1996-10-01 Carbostyril derivative for curing ophthalmological diseases

Publications (1)

Publication Number Publication Date
DK0859615T3 true DK0859615T3 (da) 2001-09-03

Family

ID=26398366

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96932058T DK0859615T3 (da) 1995-10-12 1996-10-01 Carbostyrilderivat til helbredelse af ophthalmologiske sygdomme

Country Status (16)

Country Link
US (1) US6060486A (da)
EP (1) EP0859615B1 (da)
KR (1) KR100281865B1 (da)
CN (1) CN1132580C (da)
AR (3) AR004214A1 (da)
AT (1) ATE201992T1 (da)
AU (1) AU709734B2 (da)
CA (1) CA2234247C (da)
DE (1) DE69613386T2 (da)
DK (1) DK0859615T3 (da)
ES (1) ES2159043T3 (da)
GR (1) GR3036457T3 (da)
MX (1) MX9802817A (da)
PT (1) PT859615E (da)
TW (1) TW446702B (da)
WO (1) WO1997013515A1 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6506412B2 (en) 2000-11-29 2003-01-14 Sciencebased Health Treatment of dry eye syndrome
US6623754B2 (en) * 2001-05-21 2003-09-23 Noveon Ip Holdings Corp. Dosage form of N-acetyl cysteine
DE10133870A1 (de) * 2001-07-12 2003-02-06 Chris P Lohmann Ophthalmisches Mittel, Verwendung von EGF zur Behandlung von Dry Eye-Syndrom und Insert zur Verabreichung von EGF am Auge
KR100907407B1 (ko) * 2002-09-28 2009-07-10 주식회사 케이티 대량 메시지 동보 전송을 위한 메시지 예약 및 전송 방법
ATE373502T1 (de) * 2003-07-30 2007-10-15 Otsuka Pharma Co Ltd Carbostyril-derivative zur beschleunigten speichelabsonderung
US7829544B2 (en) * 2003-11-14 2010-11-09 Senju Pharmaceutical Co., Ltd. Aqueous solution preparation containing aminoglycoside antibiotic and bromfenac
TWI340650B (en) * 2004-01-21 2011-04-21 Otsuka Pharma Co Ltd Amine saly of carbostyril derivative
CN101005834A (zh) 2004-08-27 2007-07-25 千寿制药株式会社 干眼症治疗用滴眼液
TWI363626B (en) 2004-11-15 2012-05-11 Otsuka Pharma Co Ltd Aqueous ophthalmic suspension of crystalline rebamipide
TW200808375A (en) * 2006-05-12 2008-02-16 Otsuka Pharma Co Ltd Hydrogel suspension and manufacturing process thereof
TWI415629B (zh) * 2006-10-26 2013-11-21 Otsuka Pharma Co Ltd 含有瑞巴匹特之水性醫藥懸浮物及其製造方法
DK2285413T3 (da) * 2008-06-19 2012-08-27 Otsuka Pharma Co Ltd Farmaceutisk sammensætning
CN103476753B (zh) 2011-02-25 2015-12-09 诺弗米克斯有限公司 新的瑞巴派特复合物和共晶体
TW201322982A (zh) 2011-11-01 2013-06-16 Otsuka Pharma Co Ltd 用於治療前眼疾病之藥劑,該藥劑包含瑞巴派特及眼淚保持劑
KR101692578B1 (ko) * 2013-04-18 2017-01-03 삼진제약주식회사 레바미피드 또는 이의 전구체를 포함하는 안구건조증의 예방 또는 치료를 위한 경구용 약제학적 조성물
WO2015168629A1 (en) 2014-05-02 2015-11-05 Massachusetts Eye And Ear Infirmary Grading corneal fluorescein staining
KR102307958B1 (ko) 2015-10-01 2021-10-05 삼진제약주식회사 레바미피드를 함유하는 신규한 점안 조성물 및 이의 제조방법
KR20170039347A (ko) 2015-10-01 2017-04-11 삼진제약주식회사 레바미피드를 함유하는 신규한 점안 조성물 및 이의 제조방법
CN110891555B (zh) * 2017-03-05 2023-12-26 雷斯德沃克研究及发展有限公司 用于治疗非因感染引起的刺激的滴眼剂
KR102615076B1 (ko) 2021-07-14 2023-12-19 대우제약 주식회사 안정한 레바미피드 점안제의 대용량 제조 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI80022C (fi) * 1982-07-05 1990-04-10 Otsuka Pharma Co Ltd Foerfarande foer framstaellning av ett nytt, terapeutiskt anvaendbart karbostyrilderivat.
JPH0713138B2 (ja) * 1986-07-30 1995-02-15 保土谷化学工業株式会社 ポリテトラメチレンエ−テルグリコ−ルの製法
CA2088582A1 (en) * 1991-06-07 1992-12-08 Katsuya Yamasaki Anti-diabetes mellitus
TW227558B (da) * 1992-05-14 1994-08-01 Otsuka Pharma Co Ltd
TW290541B (da) * 1993-03-18 1996-11-11 Otsuka Pharma Factory Inc
AU683697B2 (en) * 1993-10-21 1997-11-20 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivative for inhibiting production of interleukin-8
WO1996004911A1 (en) * 1994-08-10 1996-02-22 Otsuka Pharmaceutical Co., Ltd. Method of preventing and treating ophthalmic inflammation and/or wound

Also Published As

Publication number Publication date
ES2159043T3 (es) 2001-09-16
ATE201992T1 (de) 2001-06-15
AR055393A2 (es) 2007-08-22
CN1132580C (zh) 2003-12-31
KR100281865B1 (ko) 2001-02-15
AU7097596A (en) 1997-04-30
DE69613386T2 (de) 2002-05-23
WO1997013515A1 (en) 1997-04-17
DE69613386D1 (de) 2001-07-19
CA2234247C (en) 2005-05-10
AU709734B2 (en) 1999-09-02
MX9802817A (es) 1998-09-30
US6060486A (en) 2000-05-09
CN1202108A (zh) 1998-12-16
EP0859615A1 (en) 1998-08-26
EP0859615B1 (en) 2001-06-13
PT859615E (pt) 2001-09-28
AR004214A1 (es) 1998-11-04
TW446702B (en) 2001-07-21
AR070051A2 (es) 2010-03-10
CA2234247A1 (en) 1997-04-17
KR19990064187A (ko) 1999-07-26
GR3036457T3 (en) 2001-11-30

Similar Documents

Publication Publication Date Title
DK0859615T3 (da) Carbostyrilderivat til helbredelse af ophthalmologiske sygdomme
DK0730864T3 (da) Lægemiddel til behandling af inflammatoriske hjertesygdomme
NO965377L (no) Indolinonforbindelser for behandling av sykdommer
DK0785792T3 (da) Præparat til behandling af ovariale af østrogen afhængige sygdomme
DK1028954T3 (da) Substituerede imidazoler egnede til behandling af inflammatoriske sygdomme
NO20010556D0 (no) Fremgangsmåte for oftalmisk administrering
DK0941103T3 (da) Farmaceutisk præparat til behandling af diabetes
FI972945A (fi) Antigeenien antamiseen soveltuvia koostumuksia
ATE187063T1 (de) Arzneimittel
DK0841946T3 (da) Metoder til behandling af allergisk astma
NO910395L (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 4-isoxazolcarboxamidderivater.
NO985066D0 (no) Terapeutisk behandling for VEGF-relaterte sykdommer
DK0979079T3 (da) Anvendelse af tetrahydropyridinderivater til fremstilling af lægemidler til behandling af sygdomme, der medförer en demyelinisering
NO995251D0 (no) FremgangsmÕte for administrering av haloterapi
NO953254D0 (no) Substituerte azolonderivater for behandling av sykdommer forårsaket av helikobakter
DK0768310T3 (da) Fremgangsmåde til fremstilling af imidazo-benzodiazepin-derivater
PT983275E (pt) Novos derivados do triptolido vantajosos para o tratamento de doencas autoimunes
DK0877738T3 (da) Fremgangsmåde til fremstilling af phenylimidazolidinderivater
NO991733D0 (no) FremgangsmÕte for fremstilling av et IgM-preparat for intraven°s administrering
NO20024060L (no) Fremgangsmåte for fremstilling av et oksazolyletanolderivat
DE69618560T2 (de) Medikament gegen ophthalmische erkrankungen
NO991734D0 (no) Pyrazolinoner for behandling av potensforstyrrelser
EE03437B1 (et) Benseenamiidid neurodegeneratiivsete haiguste ravimiseks
NO913117L (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
NO991164D0 (no) Farmas°ytisk preparat for behandling av virussykdommer